» Articles » PMID: 33953856

Comparative Study of Gavage and Intraperitoneal Administration of Gamma-oryzanol in Alleviation/attenuation in a Rat Animal Model of Renal Ischemia/reperfusion-induced Injury

Overview
Specialty General Medicine
Date 2021 May 6
PMID 33953856
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Ischemia/reperfusion (I/R) is the leading cause of acute kidney injury. This study aimed to elucidate the reno-protective effect of gamma-oryzanol (GO) by comparing gavage and intraperitoneal (IP) administration methods on renal I/R injury in a rat model.

Materials And Methods: Rats were divided into four groups including (group 1) sham, (group 2) I/R-control, (group 3) I/R+GO gavage-treated, and (group 4) I/R+ GO IP-treated. A single dose of GO was administrated to groups 3 and 4 (100 mg/kg body weight), 60 min before induction of I/R. After anesthesia, I/R was created by 45 min of ischemia, followed by 6 hr of reperfusion. Then, blood and tissue samples were subjected to evaluation of renal function, anti-oxidant capacity, inflammation, apoptotic proteins, and IKB/NF-kB pathway.

Results: The two GO administration methods showed improvement of renal function along with attenuation of histological abnormalities. An increase in antioxidant capacity along with a decrease in pro-inflammatory markers, decline in the expression levels of BAX, Bax/Bcl-2, and caspase-3, and up-regulation of Bcl-2 expression were recorded. Moreover, a significant decrease in NF-Kb, p-IKBα, and MMP-2/9 with an increase in IKBα levels were also observed. Overall, in a comparative evaluation between the two gavage and IP administration methods, we did not find any differences in all examined parameters, except IL-6 which had a better result via gavage.

Conclusion: A single dose of GO administration has a reno-protective effect against renal I/R injury. Gavage and IP administration exhibit similar efficiency in alleviation of I/R injury.

Citing Articles

Yinjia pills inhibits the malignant biological behavior of HeLa cells through PKM2-medicated inhibition of JAK/STAT3 pathway.

Shi Y, Min X, Li Y, Guo L, Cai Z, Li D Cytotechnology. 2024; 77(1):5.

PMID: 39575323 PMC: 11579276. DOI: 10.1007/s10616-024-00668-5.


NaHS protects brain, heart, and lungs as remote organs from renal ischemia/reperfusion-induced oxidative stress in male and female rats.

Saberi S, Najafipour H, Rajizadeh M, Etminan A, Jafari E, Iranpour M BMC Nephrol. 2024; 25(1):373.

PMID: 39438873 PMC: 11515705. DOI: 10.1186/s12882-024-03824-3.


Single-cell dissection reveals promotive role of ENO1 in leukemia stem cell self-renewal and chemoresistance in acute myeloid leukemia.

Tian Y, Guo J, Mao L, Chen Z, Zhang X, Li Y Stem Cell Res Ther. 2024; 15(1):347.

PMID: 39380054 PMC: 11463110. DOI: 10.1186/s13287-024-03969-w.


Cytokines secreted from bone marrow-derived mesenchymal stem cells promote apoptosis of CD34 leukemic stem cells as anti-cancer therapy.

Farahzadi R, Fathi E, Vandghanooni S, Valipour B Regen Ther. 2024; 26:646-653.

PMID: 39281104 PMC: 11401101. DOI: 10.1016/j.reth.2024.08.008.


Proteasome and PARP1 dual-target inhibitor for multiple myeloma: Fluzoparib.

Deng K, Li Q, Lu L, Wang L, Cheng Z, Wang S Biochem Biophys Rep. 2024; 39:101781.

PMID: 39071914 PMC: 11279668. DOI: 10.1016/j.bbrep.2024.101781.


References
1.
Zolali E, Asgharian P, Hamishehkar H, Kouhsoltani M, Khodaii H, Hamishehkar H . Effects of gamma oryzanol on factors of oxidative stress and sepsis-induced lung injury in experimental animal model. Iran J Basic Med Sci. 2016; 18(12):1257-63. PMC: 4744368. View

2.
Granger D, Kvietys P . Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol. 2015; 6:524-551. PMC: 4625011. DOI: 10.1016/j.redox.2015.08.020. View

3.
Tarhriz V, Eyvazi S, Musavi M, Abasi M, Sharifi K, Ghanbarian H . Transient induction of Cdk9 in the early stage of differentiation is critical for myogenesis. J Cell Biochem. 2019; 120(11):18854-18861. DOI: 10.1002/jcb.29204. View

4.
Gao D, Jing S, Zhang Q, Wu G . Pterostilbene protects against acute renal ischemia reperfusion injury and inhibits oxidative stress, inducible nitric oxide synthase expression and inflammation in rats via the Toll-like receptor 4/nuclear factor-κB signaling pathway. Exp Ther Med. 2018; 15(1):1029-1035. PMC: 5780844. DOI: 10.3892/etm.2017.5479. View

5.
Martin J, Gruszczyk A, Beach T, Murphy M, Saeb-Parsy K . Mitochondrial mechanisms and therapeutics in ischaemia reperfusion injury. Pediatr Nephrol. 2018; 34(7):1167-1174. PMC: 6366561. DOI: 10.1007/s00467-018-3984-5. View